Showing 361 - 380 results of 5,248 for search '"Vascular endothelial growth factor"', query time: 0.27s Refine Results
  1. 361

    Decreases in GSH:GSSG activate vascular endothelial growth factor receptor 2 (VEGFR2) in human aortic endothelial cells by Priya K. Prasai, Bandana Shrestha, A. Wayne Orr, Christopher B. Pattillo

    Published 2018-10-01
    “…Elevated reactive oxygen species production, commonly associated with ischemic injury, has been shown to promote phosphorylation of the vascular endothelial growth factor receptor 2 (VEGFR2), a critical regulator of angiogenesis. …”
    Get full text
    Article
  2. 362

    POLYMORPHISM C634G OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR A GENE IN PATIENTS WITH DIABETIC FOOT IN THE TRANS-BAIKAL TERRITORY by Наталья Игоревна Троицкая, Константин Геннадьевич Шаповалов

    Published 2023-08-01
    “…The study involved 199 patients with a mixed form of diabetic foot syndrome and 100 practically healthy people, in whom the frequency of occurrence of genotype variants and the C634G polymorphism alley of the vascular endothelial growth factor A gene was studied by polymerase chain reaction. …”
    Get full text
    Article
  3. 363

    Overexpression of vascular endothelial growth factor enhances the neuroprotective effects of bone marrow mesenchymal stem cell transplantation in ischemic stroke by Cui Liu, Zhi-Xiang Yang, Si-Qi Zhou, Ding Ding, Yu-Ting Hu, Hong-Ning Yang, Dong Han, Shu-Qun Hu, Xue-Mei Zong

    Published 2023-01-01
    Subjects: “…bone marrow mesenchymal stem cell; brain-derived neurotrophic factor; cd31; microtubule associated protein 2; middle cerebral artery occlusion; stroke; transplantation; vascular endothelial growth factor…”
    Get full text
    Article
  4. 364

    Long-term Outcomes of Treat and Extend Regimen of Anti-vascular Endothelial Growth Factor in Neovascular Age-related Macular Degeneration by Andy Lee, Pooja G Garg, Alice T Lyon, Rukhsana Mirza, Manjot K Gill

    Published 2020-08-01
    “…Purpose: This study describes the long-term visual and anatomic outcomes of anti-vascular endothelial growth factor (VEGF) treatment using a treat and extend dosing regimen. …”
    Get full text
    Article
  5. 365
  6. 366
  7. 367
  8. 368
  9. 369

    Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study by Osama A. Sorour, Elsayed Nassar, Naglaa Sarhan, Noha El-Anwar, Reem A ElKholy, Dina M. Tahoon, Aalaa Sweilam, Dina Tadros

    Published 2023-07-01
    “…However, its effects on diabetic retinopathy (DR), which is mainly a microvascular disease, remain unclear. Vascular endothelial growth factor (VEGF) is known to be a critical mediator of DR. …”
    Get full text
    Article
  10. 370

    A 60% Edible Ethanolic Extract of <i>Ulmus davidiana</i> Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Jeongho Park, Hyun-Ouk Kim, Kwang-Hyun Park, Myung-Bok Wie, Sun-Eun Choi, Jang-Hyuk Yun

    Published 2021-02-01
    “…As abnormal angiogenesis is associated with exacerbation of various diseases, precise control over angiogenesis is imperative. Vascular endothelial growth factor (VEGF), the most well-known angiogenic factor, binds to VEGF receptor (VEGFR), activates various signaling pathways, and mediates angiogenesis. …”
    Get full text
    Article
  11. 371

    Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients by Zhao Ying-Chun, Ni Xiao-Jian, Li Yong, Dai Min, Yuan Zhong-Xu, Zhu Yong-Yun, Luo Chuan-Yu

    Published 2012-08-01
    “…<p>Abstract</p> <p>Background</p> <p>Mounting clinical and experimental data suggest that the migration of tumor cells into lymph nodes is greatly facilitated by lymphangiogenesis. Vascular endothelial growth factor (VEGF)-C and D have been identified as lymphangiogenic growth factors and play an important role in tumor lymphangiogenesis. …”
    Get full text
    Article
  12. 372

    Effect of intra-arterial heparin flushing (IAHF) to prestin and vascular endothelial growth factor (VEGF) level in hearing loss patients by Elvita Rahmi Daulay, Delfitri Munir, Aznan Lelo, Terawan Agus Putranto, Aziza Ghanie Icksan, Tengku Siti Hajar Haryuna, Putri C. Eyanoer, Tina Christina L Tobing

    Published 2023-05-01
    “…Intra-Arterial Heparin Flushing (IAHF) is an endovascular technique that uses heparin to promote reperfusion and increases Vascular Endothelial Growth Factor (VEGF) expression. VEGF is a polypeptide angiogenesis factor present in the nervous system, which functions as a neurotrophic and neuroprotective. …”
    Get full text
    Article
  13. 373
  14. 374
  15. 375

    Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice by Rajya L Gurung, Liesel M FitzGerald, Ebony Liu, Bennet J McComish, Georgia Kaidonis, Bronwyn Ridge, Alex W Hewitt, Brendan J Vote, Nitin Verma, Jamie E Craig, Kathryn P Burdon

    Published 2023-04-01
    “…Abstract Background Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are the standard of care for diabetic macular edema (DME), a common complication of diabetes. …”
    Get full text
    Article
  16. 376
  17. 377

    Discovery of Small Molecules That Target Vascular Endothelial Growth Factor Receptor-2 Signalling Pathway Employing Molecular Modelling Studies by Shailima Rampogu, Ayoung Baek, Chanin Park, Minky Son, Shraddha Parate, Saravanan Parameswaran, Yohan Park, Baji Shaik, Ju Hyun Kim, Seok Ju Park, Keun Woo Lee

    Published 2019-03-01
    “…Angiogenesis is defined as the formation of new blood vessels and is a key phenomenon manifested in a host of cancers during which tyrosine kinases play a crucial role. Vascular endothelial growth factor receptor-2 (VEGFR-2) is pivotal in cancer angiogenesis, which warrants the urgency of discovering new anti-angiogenic inhibitors that target the signalling pathways. …”
    Get full text
    Article
  18. 378

    Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas by Aurore Dumond, Christopher Montemagno, Valérie Vial, Renaud Grépin, Gilles Pagès

    Published 2021-05-01
    “…Relapse following anti-angiogenic treatment depends on the over-expression of vascular endothelial growth factor C (VEGFC), one of the main drivers of lymphangiogenesis. …”
    Get full text
    Article
  19. 379

    Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization by Müge Çoban Karataş, Gürsel Yılmaz, Aslıhan Yüce Sezen, Çağla Sarıtürk

    Published 2022-02-01
    “…Objectives:To compare best corrected visual acuity (BCVA), central macular thickness (CMT), and central choroidal thickness (CCT) in patients with type 2 macular telangiectasia (MacTel 2) and a control group and to evaluate the efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in MacTel 2 patients with macular neovascularization (MNV).Materials and Methods:We conducted a retrospective chart review of consecutive MacTel 2 patients who underwent a full ophthalmologic examination including BCVA and dilated fundus examination with slit-lamp biomicroscopy, fluorescein angiography, and optical coherence tomography imaging at baseline and follow-up visits. …”
    Get full text
    Article
  20. 380